Rheumatoid Arthritis Clinical Trials in Miami, Florida

3 studies are recruiting for rheumatoid arthritis in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

    Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity. Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. The purpose of this study is to assess the pharmacokinetics, …

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Allied Biomedical Research Institute /ID# 284408, Miami, Florida
    Locations
    13 in total
    Run by
    AbbVie

    See if you can join NCT07607964 on ClinicalTrials.gov

  2. Phase 1b/2 Study of IV Sarilumab in Adult With RA

    This is a Phase 1/Phase 2 study with: * 5-arms design for Part A; * and a single arm for Part B. The purpose of this study is to measure PK parameters and safety with sarilumab intravenous (IV) with or without concomitant oral conventional synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rheumwell Comprehensive Rheumatology- Site Number : 8400019, Miami, Florida
    Locations
    12 in total
    Run by
    Sanofi

    See if you can join NCT07704580 on ClinicalTrials.gov

  3. A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

    This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Nkarta Investigational Site, Miami, Florida
    Locations
    18 in total
    Run by
    Nkarta, Inc.

    See if you can join NCT06733935 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.